Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NOX-A12: mobilizing CLL away from home.

Literature DB >> 24526776

NOX-A12: mobilizing CLL away from home.

Roberto Marasca¹, Rossana Maffei.

Abstract

Mesh：

Substances：

Year: 2014 PMID： 24526776 DOI： 10.1182/blood-2013-12-542480

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Targeting the microenvironment in acute myeloid leukemia.

Authors: Armin Rashidi; Geoffrey L Uy
Journal: Curr Hematol Malig Rep Date: 2015-06 Impact factor: 3.952

Review 2. Aptamers as targeted therapeutics: current potential and challenges.

Authors: Jiehua Zhou; John Rossi
Journal: Nat Rev Drug Discov Date: 2016-11-03 Impact factor: 84.694

Review 3. Aptamers: A promising chemical antibody for cancer therapy.

Authors: Gang Zhou; George Wilson; Lionel Hebbard; Wei Duan; Christopher Liddle; Jacob George; Liang Qiao
Journal: Oncotarget Date: 2016-03-22

Review 4. Aptamer Therapeutics in Cancer: Current and Future.

Authors: Yoshihiro Morita; Macall Leslie; Hiroyasu Kameyama; David E Volk; Takemi Tanaka
Journal: Cancers (Basel) Date: 2018-03-19 Impact factor: 6.639

Review 5. The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

Authors: John P Veluchamy; Nina Kok; Hans J van der Vliet; Henk M W Verheul; Tanja D de Gruijl; Jan Spanholtz
Journal: Front Immunol Date: 2017-05-31 Impact factor: 7.561

NOX-A12: mobilizing CLL away from home.

Review 1. Targeting the microenvironment in acute myeloid leukemia.

Review 2. Aptamers as targeted therapeutics: current potential and challenges.

Review 3. Aptamers: A promising chemical antibody for cancer therapy.

Review 4. Aptamer Therapeutics in Cancer: Current and Future.

Review 5. The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

Review 6. Aptamers in the Therapeutics and Diagnostics Pipelines.

Review 7. Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease.

Review 8. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.

Review 9. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.

Review 10. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.